RISW2026
Back to all people

Hana Lee

Food and Drug Administration
6 appearances in the program

Sessions & presentations

PS44: Target Trial Emulation for Regulatory-Grade Real-World Evidence Generation in Rare Diseases and Oncology: Case Studies and An Expert Panel Discussion
Presentation: Regulatory Perspectives on Methodological Frameworks for Real-World Evidence
Parallel · Fri, Sep 18 , 1:30 PM
Presenting Author
PS44: Target Trial Emulation for Regulatory-Grade Real-World Evidence Generation in Rare Diseases and Oncology: Case Studies and An Expert Panel Discussion
Presentation: Panel Discussion
Parallel · Fri, Sep 18 , 1:30 PM
Panelist
PS22: Harnessing Real-World Evidence (RWE) in Regulatory Submissions: Advances, Methodologies, and Practical Applications
Parallel · Thu, Sep 17 , 4:15 PM
Co-Organizer
PS22: Harnessing Real-World Evidence (RWE) in Regulatory Submissions: Advances, Methodologies, and Practical Applications
Parallel · Thu, Sep 17 , 4:15 PM
Discussant
PS22: Harnessing Real-World Evidence (RWE) in Regulatory Submissions: Advances, Methodologies, and Practical Applications
Presentation: TMLE for Regulatory Purposes: A Landscape Overview
Parallel · Thu, Sep 17 , 4:15 PM
Presenting Author
Poster Session I
Presentation: A CV-TMLE Global Test Approach to Multiple-Component Endpoints in Rare Disease Clinical Trials
Posters · Thu, Sep 17 , 5:45 PM
CoAuthor
↑